<p>Tien-Li Lee, Chief Executive Officer and Director of Aardvark Therapeutics Inc., reported the acquisition of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aardvark Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-318069), on December 12, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

AARD

<p>Tien-Li Lee, CEO and Director of Aardvark Therapeutics Inc., reported the acquisition of common shares of the company, as per a recent SEC filing.</p>

Aardvark Therapeutics CEO Tien-Li Lee Reports Acquisition of Common Shares